SCHEMBL7209352

SCHEMBL7209352

COc1ccc(S(=O)(=O)Nc2ccccc2C(=O)Nc2ccc(OC)c(Cl)c2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AVPR2 P30518 2/20 0.59
GPR27 Q9NS67 2/20 0.59
ALDH1A1 P00352 8/20 0.59
MEN1 O00255 5/20 0.59
KMT2A Q03164 5/20 0.59
MAPK1 P28482 1/20 0.59
SMN1; SMN2 Q16637 6/20 0.58
MAPT P10636 5/20 0.58
HPGD P15428 3/20 0.58
NPC1 O15118 1/20 0.58
RAB9A P51151 1/20 0.58
LMNA P02545 5/20 0.58
HTT P42858 4/20 0.58
PNLIP P16233 1/20 0.56
KDM4E B2RXH2 2/20 0.55
CYP3A4 P08684 2/20 0.55
CYP2D6 P10635 2/20 0.55
CYP2C9 P11712 2/20 0.55
CYP2C19 P33261 2/20 0.55
CRHBP P24387 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7208217 0.92 MEN1 (0.59) AVPR2GPR27ALDH1A1MEN1KMT2A
SCHEMBL27580344 0.88 KMT2A (0.55) AVPR2GPR27ALDH1A1MEN1KMT2A
SCHEMBL7538011 0.84 LMNA (0.55) AVPR2GPR27ALDH1A1MEN1KMT2A
SCHEMBL7213042 0.84 LMNA (0.69) AVPR2GPR27ALDH1A1MEN1KMT2A
SCHEMBL23200348 0.83 LMNA (0.68) AVPR2GPR27ALDH1A1MEN1KMT2A
SCHEMBL30257110 0.83 LMNA (0.68) AVPR2GPR27ALDH1A1MEN1KMT2A
SCHEMBL29834290 0.83 LMNA (0.68) AVPR2GPR27ALDH1A1MEN1KMT2A
SCHEMBL23200273 0.83 LMNA (0.68) AVPR2GPR27ALDH1A1MEN1KMT2A
SCHEMBL7208708 0.80 GPR27 (0.63) AVPR2GPR27ALDH1A1MEN1KMT2A
SCHEMBL5622490 0.80 HPGD (0.72) ALDH1A1MEN1KMT2AMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1187531-A4 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2003-05-28 EP claimed
US-6458845-B1 METHOD OF ANTAGONIZING A MACROPHAGE SCAVENGER RECEPTOR COMPRISING ADMINISTERING TO A SUBJECT IN NEED OF TREATMENT AN EFFECTIVE AMOUNT OF AN N-PHENYL-2-(3-TRIFLUOROMETHYLPHENYLSULFONAMIDO)BENZAMIDE, A SMITHKLINE BEECHAM CORPORATION 2002-10-01 US claimed
CN-1358062-A Macrophage scavenger receptor antagonists SMITHKLINE BEECHAM CORP (US) 2002-07-10 CN claimed
EP-1187531-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SmithKline Beecham Corporation (US) 2002-03-20 EP claimed
WO-2001098264-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-27 WO claimed
WO-2000078145-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2000-12-28 WO claimed
EP-1187531-A4 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2003-05-28 EP disclosed
US-6458845-B1 METHOD OF ANTAGONIZING A MACROPHAGE SCAVENGER RECEPTOR COMPRISING ADMINISTERING TO A SUBJECT IN NEED OF TREATMENT AN EFFECTIVE AMOUNT OF AN N-PHENYL-2-(3-TRIFLUOROMETHYLPHENYLSULFONAMIDO)BENZAMIDE, A SMITHKLINE BEECHAM CORPORATION 2002-10-01 US disclosed
CN-1358062-A Macrophage scavenger receptor antagonists SMITHKLINE BEECHAM CORP (US) 2002-07-10 CN disclosed
EP-1187531-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SmithKline Beecham Corporation (US) 2002-03-20 EP disclosed
WO-2001098264-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-27 WO disclosed
WO-2000078145-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2000-12-28 WO disclosed